| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |